Literature DB >> 11673563

Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.

M Sekiguchi1, Y Futei, Y Fujii, T Iwasaki, T Nishikawa, M Amagai.   

Abstract

Desmoglein (Dsg) is a cadherin-type adhesion molecule found in desmosomes. Dsg1 and Dsg3 are the target Ags in the autoimmune blistering diseases pemphigus foliaceus (PF) and pemphigus vulgaris (PV), respectively. To map conformational epitopes of Dsg1 and Dsg3 in PF and PV, we generated Dsg1- and Dsg3-domain-swapped molecules and point-mutated Dsg3 molecules with Dsg1-specific residues by baculovirus expression. The swapped domains were portions of the N-terminal extracellular domains of Dsg1 (1-496) and Dsg3 (1-566), which have similar structures but distinct epitopes. The binding of autoantibodies to the mutant molecules was assessed by competition ELISAs. Domain-swapped molecules containing the N-terminal 161 residues of Dsg1 and Dsg3 yielded >50% competition in 30/43 (69.8%) PF sera and 31/40 (77.5%) PV sera, respectively. Furthermore, removal of Abs against the 161 N-terminal residues of Dsg1 by immunoadsorption eliminated the ability of PF sera to induce cutaneous blisters in neonatal mice. Within these N-terminal regions, most of the epitopes were mapped to residues 26-87 of Dsg1 and 25-88 of Dsg3. Furthermore, a point-mutated Dsg3 molecule containing Dsg1-specific amino acid substitutions (His(25), Cys(28), Ala(29)) reacted with anti-Dsg1 IgG, thus defining one of the epitopes of Dsg1. Using the predicted three-dimensional structure of classic cadherins as a model, these findings suggest that the dominant autoimmune epitopes in both PF and PV are found in the N-terminal adhesive surfaces of Dsgs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673563     DOI: 10.4049/jimmunol.167.9.5439

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris.

Authors:  Haiqin Zhu; Yayuan Chen; Yun Zhou; Ying Wang; Jie Zheng; Meng Pan
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

2.  p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.

Authors:  Xuming Mao; Yasuyo Sano; Jin Mo Park; Aimee S Payne
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

Review 3.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity.

Authors:  Jun Yamagami; Aimee S Payne; Stephen Kacir; Ken Ishii; Don L Siegel; John R Stanley
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

5.  Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.

Authors:  Flor Evangelista; Aleeza J Roth; Phillip Prisayanh; Brenda R Temple; Ning Li; Ye Qian; Donna A Culton; Zhi Liu; Oliver J Harrison; Julia Brasch; Barry Honig; Lawrence Shapiro; Luis A Diaz
Journal:  J Autoimmun       Date:  2018-01-04       Impact factor: 7.094

Review 6.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 7.  Diagnosis and clinical features of pemphigus foliaceus.

Authors:  Kirk A James; Donna A Culton; Luis A Diaz
Journal:  Dermatol Clin       Date:  2011-07       Impact factor: 3.478

8.  The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Authors:  Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

9.  Loss of Desmoglein Binding Is Not Sufficient for Keratinocyte Dissociation in Pemphigus.

Authors:  Franziska Vielmuth; Jens Waschke; Volker Spindler
Journal:  J Invest Dermatol       Date:  2015-08-19       Impact factor: 8.551

10.  Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris.

Authors:  Ralf Müller; Nicolas Hunzelmann; Vera Baur; Guido Siebenhaar; Elke Wenzel; Rüdiger Eming; Andrea Niedermeier; Philippe Musette; Pascal Joly; Michael Hertl
Journal:  Dermatol Res Pract       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.